Navigation Links
Americans Confused About FDA and Drug Safety
Date:9/20/2007

cent) believe that the U.S. health care system is "broken."
  • More than three-quarters believe a candidate's position on drug safety is "somewhat important" in choosing the next president.
  • A vast majority of Americans (88 percent) are confident that prescription drugs made in the United States are safe. In contrast, only 56 percent think that drugs made in Canada and Europe are safe, and only 14 percent think that drugs made in China and India are safe. Many of the drugs sold in the United States are made in China and India, Thurber noted.
  • Eighty-two percent of those polled said they trust the FDA when it comes to overseeing prescription drugs, 74 percent trust patient-advocate groups, 67 percent trust pharmaceutical companies, and 53 percent trust Congress.
  • A full 50 percent of Americans are skeptical of the ability of Congress to pass "common-sense" laws on how the FDA approves drugs, however. "Only 6 percent trust Congress to do the right thing," Thurber said.
  • But while the public trusts the FDA on the whole, they are divided about the agency's performance:

    • Of those surveyed, 53 percent said the FDA does an excellent or good job, while 47 percent rated its performance as fair or poor. Those aged 18-34 were more positive about the FDA, while seniors were more negative.
    • Few (8 percent) had either seen, read, or heard about the Food and Drug Administration Revitalization Act (FDARA).
    • People were equally divided on whether the FDA's review of new drugs should be paid for by the drug industry -- 47 percent were for the move, and 46 percent were against it.
    • Only 54 percent knew that the FDA approved all prescription drugs, while 37 percent thought that the FDA approved only some drugs.
    • Many people were confused about where the FDA gets its funding. Fifty-four percent said the government, 20 percent said drug companies, and 17 percent said bot
      '/>"/>

    Copyright©2007 ScoutNews,LLC.
    All rights reserved

    Page: 1 2 3 4

    Related medicine news :

    1. Poll Finds Many Americans Misinformed About Cancer
    2. Poll Finds Many Americans Misinformed About Cancer
    3. Hypertension Drug of Choice for African Americans
    4. 38 million Americans including 14 million children left to combat hunger
    5. Americans Consume Far Too Much Salt and Sodium
    6. Americans Growing Out Of Shape
    7. Rise in Stress among Americans
    8. Home Remedies More Used By Blacks And Native Americans
    9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
    10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
    11. Americans Not Interested In Choosing Sex Of Child: Survey
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
    (Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
    (Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
    (Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
    Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
    ...A large number of doctors in Portugal were refusin...tting abortions up to the 10th week of pregnancy ....ctors" and press reports indicated at least nine p...a total of 50 could not guarantee the procedure. ...
    ...China will mass-produce a Cuban pesticide effectiv...n ministry said Sunday . Cuban scientists develop...ls larvae of the Aedes aegypti mosquito, the dengu...statement said. According to the agreement, China...
    ...A new study has examined whether a vaccine that of...asing risky behaviour , as a false sense of securi...herwise would be. While the study looks at the r... its authors suggest the research also sheds light...
    ...A recent research has found that a suntan is the b...fects of ultraviolet (UV) light .Researchers at th...in Boston have conducted a series of experiments a...the body from the cancerous effects of ultraviolet...
    Other Medicine News:Health News:Efficacy of Lyme Disease Vaccination Examined 2
    (Date:10/3/2008)...e newest study site, PHILADELPHIA, Oct. 3 /PRNews...ladelphia today received a contract to manage a ne...ldren,s Hospital will manage local,participation, ...ty, New,Jersey. The study is funded by the Nationa... approximately 1,000 families in Burlington,County...
    (Date:10/2/2008)...f Rosetta Genomics, microRNA-based,Test, miRview(T...n Squamous non Small Cell Lung Cancer, With C...view(TM) Technology First Approved for Clinical us... Molecular Pathology Lab ... to Launch miRview(TM) Squamous Later This Ye...
    (Date:10/2/2008)...stCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; T...ed on,endocrine therapy and oncology, today report... recruitment for its Phase 2 trial in ovarian canc...hormone (LHRH) agonist,linked to doxorubicin. The ...uitment was taken following recent first stage dat...
    (Date:10/1/2008)...ingual lozenge) developed to be the first sleep a... when patients awaken and have difficulty .../- Transcept Pharmaceuticals,Inc., a...announced today,that it has submitted a New Drug A...tration (FDA) for its lead product candidate, Inte...
    Breaking Medicine Technology:The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Dawning Technologies Inc and Medical Automation Systems Inc to Develop a Business Partnership 20850 1Dawning Technologies Inc and Medical Automation Systems Inc to Develop a Business Partnership 20850 2Haemacure Reports on Financing Progress and Second Quarter Results 20846 1Haemacure Reports on Financing Progress and Second Quarter Results 20846 2Haemacure Reports on Financing Progress and Second Quarter Results 20846 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 1US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 5Vaccine may double survival in patients with deadly brain tumors 20841 1Vaccine may double survival in patients with deadly brain tumors 20841 2
    Straight shafts with 1 x 2 teeth and serrated handle with polished finish.
    Smooth 90 degree jaws with locking screw maintain proper stretch of sleeve for securing silicone bands.
    Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 gauge shaft tapering to 23 gauge, 10 mm from tip. Overall length from rear rotation knob to tip.
    Ergotec Vetriretinal Instrument System. Ultra-fine 0.8 mm tips. Angled 40 degrees. 20 gauge shaft tapers to 23 gauge.
    Medicine Products: